Published in Transplantation on March 01, 1990
FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats. Transplantation (1990) 2.13
Identification, characterization, and quantitation of soluble HLA antigens in the circulation and peritoneal dialysate of renal patients. Ann Surg (1991) 0.99
Soluble HLA: patterns of expression in normal subjects, autoimmune diseases, and transplant recipients. Rheumatol Int (2005) 0.78
Soluble HLA measurement in saliva and cerebrospinal fluid in Caucasian patients with multiple sclerosis: a preliminary study. J Neuroinflammation (2005) 0.77
Saliva soluble HLA as a potential marker of response to interferon-beta 1a in multiple sclerosis: a preliminary study. J Neuroinflammation (2007) 0.76
The possible anti-inflammatory role of circulating human leukocyte antigen levels in women with endometriosis after treatment with danazol and leuprorelin acetate depot. Mediators Inflamm (2001) 0.76
Examination of serum class I antigen in liver-transplanted rats. Clin Exp Immunol (1991) 0.75
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29
Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet (1979) 6.10
Induction of immunological tolerance by porcine liver allografts. Nature (1969) 5.89
Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation (1979) 5.12
Liver transplantation in man. I. Observations on technique and organization in five cases. Br Med J (1968) 4.38
Improved survival after orthotopic liver grafting. Br Med J (Clin Res Ed) (1981) 3.09
Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg (1988) 3.04
Use of partial cardiopulmonary bypass during the anhepatic phase of orthotopic liver grafting. Lancet (1979) 2.98
A new technique for biliary drainage in orthotopic liver transplantation utilizing the gall bladder as a pedicle graft conduit between the donor and recipient common bile ducts. Ann Surg (1976) 2.86
Cyclosporin A in cadaveric organ transplantation. Br Med J (Clin Res Ed) (1981) 2.67
Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A. Lancet (1978) 2.57
Liver transplantation. Curr Probl Surg (1979) 2.57
Rapamycin for immunosuppression in organ allografting. Lancet (1989) 2.51
Orthotopic liver transplantation: the first 60 patients. Br Med J (1977) 2.50
Soluble HLA antigens in the circulation of liver graft recipients. Transplantation (1989) 2.48
A surgical experience with five hundred thirty liver transplants in the rat. Surgery (1983) 2.48
Some personal observations on the university department of surgery. Ann R Coll Surg Engl (1977) 2.46
Prolonged survival of liver transplants in the pig. Br Med J (1967) 2.14
Cyclosporine: five years' experience in cadaveric renal transplantation. N Engl J Med (1984) 2.10
Simple hypothermic preservation for transporting human livers long distances for transplantation. Report of 12 cases. Transplantation (1977) 2.08
Liver transplantation in man: the frequency of rejection, biliary tract complications, and recurrence of malignancy based on an analysis of 26 cases. Gastroenterology (1973) 1.99
Transplant surgery: current status. Br J Surg (1980) 1.95
Cyclosporin A: preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants. Transplant Proc (1979) 1.94
Bile composition and bile cast formation after transplantation of the liver in man. Transplantation (1975) 1.92
Liver transplantation in 100 children: Cambridge and King's College Hospital series. BMJ (1992) 1.90
Liver transplantation in patients with alcoholic cirrhosis: selection criteria and rates of survival and relapse. BMJ (1990) 1.88
Hypercalcemia and increased parathyroid-hormone activity in a primary hepatoma. Studies before and after hepatic transplantation. N Engl J Med (1970) 1.83
Breast sarcoma. A clinicopathologic review of 25 cases. Cancer (1990) 1.77
Gastrointestinal complications after renal transplantation. Lancet (1971) 1.71
Observations of orthotopic liver transplantation in the pig. Br Med J (1967) 1.69
Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation. Lancet (1987) 1.68
Liver transplantation in man. II. A report of two orthotopic liver transplants in adult recipients. Br Med J (1968) 1.68
Liver transplantation. Transplant Rev (1969) 1.67
Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: results of a prospective randomized trial. Am J Transplant (2008) 1.67
Outcome of HIV infection in transplant patient on cyclosporin. Lancet (1991) 1.66
Combined mediastinal and retroperitoneal fibrosis. Lancet (1966) 1.66
Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med (1982) 1.64
Cyclosporin A stimulates proliferation of the liver cells after partial hepatectomy in rats. Surg Gynecol Obstet (1988) 1.60
Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation. Lancet (1988) 1.60
Differentiation between specific and non-specific hepatitis C antibodies in chronic liver disease. Lancet (1990) 1.57
Administration of heparin and antibiotic prophylaxis. Br J Surg (1994) 1.55
Cellular immune response during rejection of a liver transplant in man. Nature (1969) 1.55
Observations on preservation, bile drainage and rejection in 64 human orthotopic liver allografts. Ann Surg (1977) 1.53
The effect of liver transplantation in a 13-year-old boy with erythropoietic protoporphyria. Transplantation (1988) 1.51
The prevention of renal impairment in patients undergoing orthotopic liver grafting by infusion of low dose dopamine. Anaesthesia (1987) 1.47
Familial HBsAg-positive hepatoma: treatment with orthotopic liver transplantation and specific immunoglobulin. Br Med J (1978) 1.46
Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome. J Hepatol (1993) 1.43
Plasma lipids following renal transplantation. Transplantation (1973) 1.42
Cadaveric kidneys for transplantation. Br Med J (1969) 1.39
Successful use of size-mismatched liver allografts in children by delayed primary closure of the abdominal wall. Br J Surg (1996) 1.39
Prolongation of canine pancreas allograft survival with cyclosporin A: preliminary report. Br Med J (1980) 1.38
Immunosuppressive effects of the orthotopically transplanted porcine liver. Transplant Proc (1969) 1.34
Glucose and insulin metabolism after pancreatic transplantation. Br Med J (1972) 1.30
Surgical self-scrutiny. Lancet (1974) 1.29
Liver transplantation for liver cancer. World J Surg (1982) 1.28
Liver transplantation in the adult. World J Surg (1986) 1.27
Effect of donor antigen on dogs with renal homotransplants. Transplantation (1966) 1.27
Graft-versus-host disease in solid organ transplantation. Transpl Int (1991) 1.27
Mode of action of cyclosporin A: a new immunosuppressive agent. Transplant Proc (1979) 1.26
Immunosuppression for organ grafting -- observations on cyclosporin A. Immunol Rev (1979) 1.26
Outcome of orthotopic liver transplantation in the aetiological and clinical variants of acute liver failure. Q J Med (1988) 1.24
Long-term use of cyclosporin in liver grafting. Q J Med (1985) 1.24
Further observations on renal transplants in man from cadaveric donors. Br Med J (1966) 1.22
Primary hyperoxaluria (type I): attempted treatment by combined hepatic and renal transplantation. Q J Med (1985) 1.22
Solitary splenic metastasis: case report and review of the literature. Am J Clin Oncol (2001) 1.20
Percutaneous needle biopsies of renal allografts: the relationship between morphological changes present in biopsies and subsequent allograft function. Histopathology (1977) 1.20
The treatment of major liver trauma by primary packing with transfer of the patient for definitive treatment. Br J Surg (1979) 1.20
Paratopic segmental pancreas grafting: a technique with portal venous drainage. Lancet (1984) 1.19
Liver preservation by single passage hypothermic "squirt" perfusion. Br Med J (1972) 1.17
Survival after renal transplantation in man: an interim report on 54 consecutive transplants. Br Med J (1968) 1.16
Cyclosporin-A in clinical organ grafting. Transplant Proc (1981) 1.16
Surgical aspects of clinical renal transplantation. Br J Surg (1969) 1.15
The state of British medicine-7. Organ transplantation. J R Soc Med (1978) 1.15
Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. Transplantation (1995) 1.14
The development of biliary "sludge" following liver transplantation. Transplant Proc (1979) 1.14
Liver transplantation in man--IV, Haemorrhage and thrombosis. Br Med J (1969) 1.14
Preservation of the porcine liver. Transplant Proc (1974) 1.13
Successful treatment of primary hyperoxaluria type I by combined hepatic and renal transplantation. Lancet (1987) 1.10
Tumour in a single kidney: nephrectomy, excision, and autotransplantation. Lancet (1971) 1.09
Technique of organ removal and fate of kidney grafts from liver donors. Transplantation (1979) 1.08
Lymphoma in renal allograft patients treated with cyclosporin-A as one of the immunosuppressive agents. Transplant Proc (1981) 1.08
Immunopathological studies of orthotopic human liver allografts. Lancet (1972) 1.07
Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation (2000) 1.07
Transplantation of liver, heart, and lungs for primary biliary cirrhosis and primary pulmonary hypertension. Lancet (1987) 1.07
Organ transplantation between widely disparate species. Transplant Proc (1970) 1.07
Nephrotoxicity of parenterally administered cyclosporine after orthotopic liver transplantation. Transplantation (1983) 1.06
Survival after orthotopic liver transplantation: a follow-up report of two patients. Br Med J (1970) 1.06
Two cases of benign lumps after treatment with cyclosporin A. Lancet (1980) 1.05
A technique of orthotopic liver translantation in the pig. Br J Surg (1968) 1.04
Biliary sludging following liver transplantation in man. Transplantation (1978) 1.03
The use of Cyclosporin A immunosuppression in organ grafting. Immunol Rev (1982) 1.02
C6: synthesis by the liver in vivo. J Exp Med (1977) 1.02
Immunosuppression in liver transplantation. N Engl J Med (1994) 1.00
Fatal generalized acute graft-versus-host disease in a liver transplant recipient. Transplantation (1990) 1.00
Posttransplant problems requiring regrafting: an analysis of 72 patients with 96 liver retransplants. Transplant Proc (1995) 0.98
Effective administration of heparin and antibiotic prophylaxis. Br J Surg (1995) 0.98
Effect of cyclosporin A on hepatocyte proliferation after partial hepatectomy in rats: comparison with standard immunosuppressive agents. Am J Surg (1988) 0.98
Cyclosporin in cadaveric renal transplantation: 3-year follow-up of a European multicentre trial. Lancet (1985) 0.97
Early renal allograft rejection episodes are less aggressive with cyclosporin-A immunosuppression. Transplant Proc (1983) 0.96